Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

’Weekend’ use matches daily drops for ’lazy eye’

02.11.2004


Adults who dispense eye drops daily to correct a child’s "lazy eye" take note: a new study from researchers at the Johns Hopkins Children’s Center and 29 other centers across North America finds that giving the drops just twice during the weekend is just as effective as administering them every day of the week.



In what is believed to be the first clinical trial comparing treatment regimens of atropine sulfate eye drops for the treatment of amblyopia, the investigators concluded that "there is no obvious advantage to the daily administration of atropine eye drops in either the speed of improvement or in the magnitude of improvement after four months of treatment," according to Michael Repka, M.D., the lead author of the study and a pediatric ophthalmologist at the Children’s Center. These findings are published by the Pediatric Eye Disease Investigator Group (PEDIG) in the November issue of Ophthalmology.

In the study, 168 children up to 7 years old with moderate amblyopia were randomly assigned to getting atropine eye drops either daily or on Saturday and Sunday only. After four months of treatment, children following both regimens were able to read an average of 2.3 lines higher on a standard eye chart. Additionally, 47 percent of children receiving daily drops and 53 percent getting weekend drops had vision in the amblyopic eye improve to normal levels by the four-month mark. This considerable degree of improvement is similar to that accomplished with daily eye patching, the mainstay of amblyopia treatment, the researchers note.


"The daily burden of administering drops usually falls on the parent, and if weekend eye drops are a good option, the regimen not only relieves some of this burden but may also encourage compliance with the treatment," Repka adds. "Compliance is very important, since timely and successful treatment for amblyopia in childhood can prevent lifelong visual impairment."

The most common cause of vision loss in children and young adults, amblyopia affects as many as 3 percent of children in the United States and usually begins in infancy or childhood. The condition is marked by poor vision in an otherwise healthy eye and occurs because the brain has learned to favor the other eye. Although the eye with amblyopia often looks normal, abnormal visual processing limits the development of a portion of the brain responsible for sight. The most common causes are crossed or wandering eyes, or significant differences in refractive error, such as farsightedness or nearsightedness, between the two eyes.

Atropine eye drops are designed to temporarily blur vision in the unaffected eye, thereby forcing the amblyopic eye to do most of the work. This helps strengthen the amblyopic eye and improves vision.

This research was conducted by the PEDIG at 30 clinical sites throughout North America and was funded by the National Eye Institute. The PEDIG focuses on studies of childhood eye disorders that can be implemented by both university-based and community-based practitioners as part of their routine practice.

Jessica Collins | EurekAlert!
Further information:
http://www.jhmi.edu

More articles from Studies and Analyses:

nachricht WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf

nachricht First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

Im Focus: Computer-Designed Customized Regenerative Heart Valves

Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.

Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Matabele ants: Travelling faster with detours

22.05.2018 | Life Sciences

Flow of cerebrospinal fluid regulates neural stem cell division

22.05.2018 | Life Sciences

Chemists at FAU successfully demonstrate imine hydrogenation with inexpensive main group metal

22.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>